US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

44.37

-0.6300-1.40%

Post-market: 44.370.00000.00%16:10 EDT

Volume:34.12K

Turnover:1.51M

Market Cap:1.51B

PE:21.03

High:44.84

Open:44.46

Low:44.00

Close:45.00

52wk High:56.59

52wk Low:39.58

Shares:34.00M

Float Shares:27.67M

Volume Ratio:0.42

T/O Rate:0.12%

Dividend:3.01

Dividend Rate:6.78%

EPS(TTM):2.11

EPS(LYR):2.11

ROE:14.08%

ROA:3.79%

PB:2.52

PE(LYR):21.03

Loading ...

Overview Company News Filings

Burger King Primed for GLP-1 Shift -- Market Talk

Global GP LLC Reports Acquisition of Global Partners LP Common Shares

Are GLP-1s The New Performance-Enhancing Drug For Careers?

ASCLETIS-B (01672) Selects Its First Oral GLP-1R/GIPR/GCGR Triple-Target Agonist Peptide ASC37 for Clinical Development

Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

GLP J-REIT Signs Interest Rate Swap Agreements to Stabilize Borrowing Costs

Global GP LLC Reports Acquisition of Global Partners LP Common Shares

GLP J-REIT Secures 11.2 Billion Yen in New Loans for Debt Refinancing

MT Newswires Live

GLP J-REIT Refinances Debt with Focus on ESG Initiatives

There's still hope GLP-1 drugs could slow the second-biggest type of dementia

Eli Lilly Benefits From 'Broadening' GLP-1 Market, Morgan Stanley Says

MT Newswires Live

Safe Supply Secures Canadian Rights to GLP-1 Technology and Announces Private Placement

MENU - ORDER AI Launches Worldwide on the Apple App Store, Delivering Real-Time High-Protein and GLP-1 Friendly Dining Guidance

Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joined the $1 trillion market cap club.

Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's

Benzinga_recent_news

Market Chatter: Eli Lilly, Novo Nordisk to Offer GLP-1 Drugs Direct to Employers

MT Newswires Live

What's Driving InMed's (INM) 22% After-Hours Surge?

Novo Nordisk Cuts Cash Price for GLP-1 Drugs

Oprah Winfrey-Backed Wellness Stock Stumbles As GLP-1 Boom Reshapes Consumer Habits: Growth Score Plummets

Benzinga_recent_news

Sinolink Securities: GLP-1 Product Iteration Drives Market Expansion, Focus on Target, Formulation, and Combination Therapy R&D Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GLP/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners LP","latestPrice":44.37,"timestamp":1774641600000,"preClose":45,"halted":0,"volume":34123,"hourTrading":{"tag":"盘后","latestPrice":44.37,"preClose":44.37,"latestTime":"16:10 EDT","volume":1218,"amount":54042.66,"timestamp":1774642204831,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.014000000000000058,"floatShares":27674174,"shares":33995563,"eps":2.11,"marketStatus":"Closed","change":-0.63,"latestTime":"03-27 16:00:00 EDT","open":44.46,"high":44.84,"low":44,"amount":1511583.2403,"amplitude":0.018667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.11,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":45,"dividendRate":0.067839,"postHourTrading":{"tag":"盘后","latestPrice":44.37,"preClose":44.37,"latestTime":"16:10 EDT","volume":1218,"amount":54042.66,"timestamp":1774642204831,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.416793,"impliedVol":0.2842,"impliedVolPercentile":0.3068},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"3.79%","roe":"14.08%","lyrEps":2.11,"volumeRatio":0.416793,"shares":33995563,"dividePrice":3.01,"high":44.84,"amplitude":0.018667,"preClose":45,"low":44,"week52Low":39.58,"pbRate":"2.52","psRate":"0.08","week52High":56.59,"institutionHeld":0.48,"latestPrice":44.37,"eps":2.11,"divideRate":0.067839,"volume":34123,"delay":0,"ttmEps":2.11,"open":44.46,"prevYearClose":41.85,"prevWeekClose":46.64,"prevMonthClose":46.98,"prevQuarterClose":41.85,"fiveDayClose":46.64,"twentyDayClose":46.98,"sixtyDayClose":42.67,"dividendPayoutRate":1.4047537053315338,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":0.045454545454545574,"fiveYearAvgDividendRate":0.07675548971847668},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-27","symbol":"GLP","fiscalQuarterEnding":"2025/12","expectedEps":0.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772168400000,"reportTimeType":"pre","actualEps":0.54},{"date":"2026-02-09","symbol":"GLP","amount":0.76,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-09","defaultRemindTime":1770647400000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-13","payableDate":"2026-02-09","currency":"USD","dateTimestamp":1770613200000,"payDate":"2026-02-13"},{"date":"2025-11-10","symbol":"GLP","amount":0.755,"announcedDate":"2025-10-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-10","defaultRemindTime":1762785000000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-14","payableDate":"2025-11-10","currency":"USD","dateTimestamp":1762750800000,"payDate":"2025-11-14"},{"market":"US","date":"2025-11-07","symbol":"GLP","fiscalQuarterEnding":"2025/09","expectedEps":1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":0.66},{"date":"2025-08-08","symbol":"GLP","amount":0.75,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-08","defaultRemindTime":1754659800000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-08-08","currency":"USD","dateTimestamp":1754625600000,"payDate":"2025-08-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-08-04","recordDate":"2016-08-08","paymentDate":"2016-08-12","value":0.4625,"currency":"USD"},{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-02-07","recordDate":"2017-02-09","paymentDate":"2017-02-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-05-08","recordDate":"2017-05-10","paymentDate":"2017-05-15","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741060800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2026-03-26","current":21.028436,"percent":0.861958,"low":2.771386,"twenty":4.440923,"median":13.133717,"eighty":18.228824,"high":29.34912,"avg":12.347989,"sd":6.519067,"marketCap":1523152231},"quantilePoints":[{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795},{"date":"2025-09-05","current":18.391039,"twenty":4.437079,"median":10.161405,"eighty":15.873833,"marketCap":1769971993},{"date":"2025-09-12","current":18.229004,"twenty":4.440923,"median":10.244717,"eighty":15.951577,"marketCap":1754377526},{"date":"2025-09-19","current":17.911977,"twenty":4.440923,"median":10.348339,"eighty":16.07924,"marketCap":1723866612},{"date":"2025-09-26","current":17.668924,"twenty":4.440923,"median":10.483035,"eighty":16.238322,"marketCap":1700474912},{"date":"2025-10-03","current":16.622738,"twenty":4.440923,"median":10.565798,"eighty":16.310589,"marketCap":1599788897},{"date":"2025-10-10","current":15.678704,"twenty":4.440923,"median":10.601474,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-10-17","current":15.460308,"twenty":4.440923,"median":10.638631,"eighty":16.329708,"marketCap":1487915548},{"date":"2025-10-24","current":16.192991,"twenty":4.440923,"median":10.724558,"eighty":16.329708,"marketCap":1558429659},{"date":"2025-10-31","current":15.978118,"twenty":4.440923,"median":10.745006,"eighty":16.329708,"marketCap":1537750040},{"date":"2025-11-07","current":15.678704,"twenty":4.440923,"median":10.777877,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-11-14","current":18.215203,"twenty":4.440923,"median":10.808766,"eighty":16.403793,"marketCap":1432862540},{"date":"2025-11-21","current":18.438808,"twenty":4.440923,"median":10.856288,"eighty":16.560326,"marketCap":1450451976},{"date":"2025-11-28","current":18.911819,"twenty":4.440923,"median":10.868211,"eighty":16.63112,"marketCap":1487660399},{"date":"2025-12-05","current":19.647135,"twenty":4.440923,"median":10.912667,"eighty":16.757487,"marketCap":1545502583},{"date":"2025-12-12","current":19.023621,"twenty":4.440923,"median":10.960835,"eighty":17.137473,"marketCap":1496455117},{"date":"2025-12-19","current":18.228104,"twenty":4.440923,"median":11.01485,"eighty":17.334253,"marketCap":1433877315},{"date":"2025-12-26","current":18.425908,"twenty":4.440923,"median":11.091519,"eighty":17.554114,"marketCap":1449437201},{"date":"2026-01-02","current":17.995898,"twenty":4.440923,"median":11.134288,"eighty":17.640744,"marketCap":1415611362},{"date":"2026-01-09","current":18.017399,"twenty":4.440923,"median":11.163158,"eighty":17.676428,"marketCap":1417302654},{"date":"2026-01-16","current":19.488032,"twenty":4.440923,"median":11.24834,"eighty":17.766657,"marketCap":1532987023},{"date":"2026-01-23","current":19.139724,"twenty":4.440923,"median":11.32675,"eighty":17.850054,"marketCap":1505588093},{"date":"2026-01-30","current":20.571656,"twenty":4.440923,"median":11.753419,"eighty":17.910997,"marketCap":1618228137},{"date":"2026-02-06","current":20.33085,"twenty":4.440923,"median":12.428533,"eighty":17.953744,"marketCap":1599285667},{"date":"2026-02-13","current":20.812461,"twenty":4.440923,"median":12.525152,"eighty":17.974678,"marketCap":1637170607},{"date":"2026-02-20","current":20.851162,"twenty":4.440923,"median":12.588448,"eighty":17.999212,"marketCap":1640214933},{"date":"2026-02-27","current":20.799561,"twenty":4.440923,"median":12.709526,"eighty":18.067895,"marketCap":1636155832},{"date":"2026-03-06","current":20.672279,"twenty":4.440923,"median":12.766265,"eighty":18.127559,"marketCap":1637616565},{"date":"2026-03-13","current":20.301456,"twenty":4.440923,"median":12.901358,"eighty":18.151279,"marketCap":1608240762},{"date":"2026-03-20","current":20.668016,"twenty":4.440923,"median":12.995923,"eighty":18.186283,"marketCap":1637278912},{"date":"2026-03-26","current":19.22735,"twenty":4.440923,"median":13.133717,"eighty":18.228824,"marketCap":1523152231}],"updateTime":1774666732667},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588044239","title":"Burger King Primed for GLP-1 Shift -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2588044239","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588044239?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:15","pubTimestamp":1764771300,"startTime":"0","endTime":"0","summary":"0914 ET - Restaurant executives are watching for signs of slower sales as more Americans take GLP-1 weight loss drugs, but Burger King owner Restaurant Brands International thinks it's prepared to meet any demand shift. Weight-loss drug users often seek out protein while using the medications, and Burger King's products are protein rich, CEO Josh Kobza said during an investor event. The chain's Double Cheeseburger is a smaller size with a high meat to bread ratio, making it a potential draw for GLP-1 users, Kobza says. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","QSR","BK4590","GLP","BK4144"],"gpt_icon":0},{"id":"2588705880","title":"Global GP LLC Reports Acquisition of Global Partners LP Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588705880","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588705880?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:38","pubTimestamp":1764625114,"startTime":"0","endTime":"0","summary":"Global GP LLC has reported the acquisition of common shares of Global Partners LP, according to a recent regulatory filing. The filing lists Global GP LLC as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Partners LP published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDLc1CWwF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Global GP LLC Reports Acquisition of Global Partners LP Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4590","BK4144"],"gpt_icon":0},{"id":"2588772817","title":"Are GLP-1s The New Performance-Enhancing Drug For Careers?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588772817","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588772817?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:01","pubTimestamp":1764608460,"startTime":"0","endTime":"0","summary":"Some professions — think tenured professor or Supreme Court justice — are largely insulated from the pressure to maintain a specific look. The same cannot be said in the high-stakes arenas of finance, real estate and design, where the quest for a competitive edge has well-established self-maintenance rituals: coloring gray hairs, meticulously curated wardrobe and submitting oneself to Botox needles.Now, that pursuit has evolved to include another new, potent class of injectable: glucagon-like peptide-1 drugs like Ozempic, Wegovy and Zepbound.While approved for diabetes and obesity, the medications are being adopted off-label by a growing cadre of professionals who see them not just as a path to better health, but as a direct investment in their career trajectory. The driving force is an open secret in many industries — being trim confers a professional and financial advantage.See Also: Forget Flipping Houses—This Fund Lets You Invest in Home Equity Like Wall Street","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/01/Ozempic--Mounjaro-Users-Cut-6-5-Billion-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/01/Ozempic--Mounjaro-Users-Cut-6-5-Billion-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/topics/25/12/49141491/are-glp-1s-the-new-performance-enhancing-drug-for-careers","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/topics/25/12/49141491/are-glp-1s-the-new-performance-enhancing-drug-for-careers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU2237443465.HKD","LU1868837136.USD","BK4588","LU0320765992.SGD","LU0708995401.HKD","LU2471134879.HKD","SGXZ31699556.SGD","IE00BWXC8680.SGD","BK4581","NVO","LU1323610961.USD","LU1804176565.USD","LU2237443895.HKD","LU0882574055.USD","LU1057294990.SGD","LU2237443622.USD","LU2750360997.AUD","LU2211815571.USD","LU0198837287.USD","IE0009355771.USD","LU2602419157.SGD","LU1548497426.USD","LU2746668461.USD","LU1023059063.AUD","IE00BJLML261.HKD","IE00BK4W5L77.USD","LU2361045086.USD","LLY","SG9999015978.USD","SGXZ99366536.SGD","LU1917777945.USD","LU2108987350.USD","LU0320765059.SGD","LU2265009873.SGD","LU0266013472.USD","LU1093756168.USD","LU1623119135.USD","LU0456855351.SGD","GB00BDT5M118.USD","LU0289739699.SGD","LU0354030511.USD","LU0109391861.USD","LU1551013342.USD","LU2112291526.USD","GLP","LU0058720904.USD","BK4599","SG9999014898.SGD","LU1988902786.USD","LU2168563687.JPY"],"gpt_icon":1},{"id":"1187203221","title":"ASCLETIS-B (01672) Selects Its First Oral GLP-1R/GIPR/GCGR Triple-Target Agonist Peptide ASC37 for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1187203221","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187203221?lang=en_us&edition=fundamental","pubTime":"2025-11-30 18:40","pubTimestamp":1764499221,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that it has selected its first oral GLP-1R/GIPR/GCGR triple-target agonist peptide, ASC37 oral tablets, as a clinical development candidate. The company plans to submit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01477","BK1191","BK1515","BK4144","BK4160","GIPR","BK1161","BK4590","01672","GLP"],"gpt_icon":0},{"id":"2587618791","title":"Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2587618791","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587618791?lang=en_us&edition=fundamental","pubTime":"2025-11-30 18:15","pubTimestamp":1764497700,"startTime":"0","endTime":"0","summary":"- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology , ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to-head non-human primate  studies.- ASC37 oral tablets' drug exposure, as measured by the area under curve , was approximately 57-fold of retatrutide's drug exposure in head-to-head NHP studies.- Average observed half-life of ASC37 oral tablets was approximately 56 hours in NHP studies, supporting once daily and less frequent oral dosing.- ASC37 in vitro activity was approximately 5-, 4- and 4-fold more potent than retatrutide for GLP-1R, GIPR and GCGR, respectively.- Submission of an Investigational New Drug Application  to the U.S. Food and Drug Administration  for ASC37 oral tablets is expected in the second quarter of 2026.\"Selection of ASC37, a promising oral GLP-1R/GIPR/GCGR triple peptide agonist,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-selects-its-first-oral-glp-1rgiprgcgr-triple-peptide-agonist-asc37-for-clinical-development-302628540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK7104","BK4144","IND","BK7095","GIPR","GLP","IND.AU","AUC.AU","BK4160"],"gpt_icon":0},{"id":"2586206014","title":"GLP J-REIT Signs Interest Rate Swap Agreements to Stabilize Borrowing Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2586206014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586206014?lang=en_us&edition=fundamental","pubTime":"2025-11-28 14:58","pubTimestamp":1764313124,"startTime":"0","endTime":"0","summary":"The latest update is out from GLP J-REIT ( ($JP:3281) ). GLP J-REIT has signed interest rate swap agreements to manage the interest rates on its re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-signs-interest-rate-swap-agreements-to-stabilize-borrowing-costs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-signs-interest-rate-swap-agreements-to-stabilize-borrowing-costs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","REIT","BK4590","BK4144"],"gpt_icon":0},{"id":"2586840476","title":"Global GP LLC Reports Acquisition of Global Partners LP Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586840476","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586840476?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:27","pubTimestamp":1764109673,"startTime":"0","endTime":"0","summary":"Global GP LLC has reported the acquisition of common shares of Global Partners LP, according to a recent SEC filing. The beneficial owner is Global GP LLC, serving as the General Partner of Global Partners LP. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Partners LP published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL9G7vBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Global GP LLC Reports Acquisition of Global Partners LP Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","GLP","BK4144"],"gpt_icon":0},{"id":"2586421914","title":"GLP J-REIT Secures 11.2 Billion Yen in New Loans for Debt Refinancing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586421914","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586421914?lang=en_us&edition=fundamental","pubTime":"2025-11-25 18:30","pubTimestamp":1764066615,"startTime":"0","endTime":"0","summary":"GLP J-REIT  will refinance 11.2 billion yen of existing debt that is maturing in December 2025 and February 2026 with new loans from a consortium of banks, according to its Tokyo bourse filing on Tuesday.The new borrowings include a 1.3 billion yen green loan from Resona Bank, which aligns with its green finance framework and is eligible for the Bank of Japan's Climate Change Operation funding.The refinancing strategy extends the maturity profile of its debt, with new repayment dates ranging from 2028 to 2033.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CFA.SI","REIT","BK4144","BK4590","GLP","BK6142","8C8U.SI"],"gpt_icon":0},{"id":"2586282464","title":"GLP J-REIT Refinances Debt with Focus on ESG Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2586282464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586282464?lang=en_us&edition=fundamental","pubTime":"2025-11-25 16:22","pubTimestamp":1764058963,"startTime":"0","endTime":"0","summary":"An update from GLP J-REIT ( ($JP:3281) ) is now available. GLP J-REIT announced a refinancing plan for its outstanding debt of 11,230 million yen, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-refinances-debt-with-focus-on-esg-initiatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glp-j-reit-refinances-debt-with-focus-on-esg-initiatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REIT","BK4144","ESG","BK4590","GLP"],"gpt_icon":0},{"id":"2586182814","title":"There's still hope GLP-1 drugs could slow the second-biggest type of dementia","url":"https://stock-news.laohu8.com/highlight/detail?id=2586182814","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586182814?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:57","pubTimestamp":1764021420,"startTime":"0","endTime":"0","summary":"Even though Novo Nordisk's GLP-1 failed in Alzheimer's trial, some researchers are cautiously optimistic that obesity and diabetes drugs may have benefits for people with vascular dementia. One study failed, but some researchers are holding out hope.There's rarely good news about Alzheimer's disease, but a failed study may open the door to more research about vascular dementia.Novo Nordisk  announced Monday that its oral GLP-1 called Rybelsus wasn't better than a placebo at delaying the progression of Alzheimer's disease. It shared few details beyond saying the semaglutide pill had failed the closely watched Phase 3 study.Novo ran two trials: evoke, which assessed Rybelsus in patients with early Alzheimer's disease, and evoke+, which was expected to enroll about 20% of patients with vascular dementia as well as people with Alzheimer's and mixed dementia, which is when a patient is diagnosed with more than one type of dementia.That's mostly because there are Alzheimer's-associated bioma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044949.HKD","LU1712237335.SGD","IE0004445239.USD","LU2237443895.HKD","SG9999014880.SGD","LU2237443549.SGD","SG9999015978.USD","NVO","LU1623119135.USD","SG9999014914.USD","LU0058720904.USD","IE00BK4W5M84.HKD","LU0320765992.SGD","LU2108987350.USD","BK4533","LU0823416689.USD","LU2023250504.SGD","LU1093756168.USD","BK4532","GLP","LU1093756325.SGD","LU1127390331.HKD","LU2211815571.USD","LU2237443622.USD","LU0289739699.SGD","LU2361044865.SGD","BK4590","LU0882574139.USD","LU0417517546.SGD","BIIB","LU1974910355.USD","IE00BJT1NW94.SGD","LU2237443382.USD","BK4534","LU1989771016.USD","IE00BK4W5L77.USD","LU1804176565.USD","LU2468319806.SGD","LU1023059063.AUD","LU2063271972.USD","SGXZ31699556.SGD","LU2417539215.USD","LU2462157665.USD","LU2361045086.USD","BK4581","BK4516","LU0079474960.USD","BK4139","IE00B19Z9P08.USD"],"gpt_icon":1},{"id":"2586392496","title":"Eli Lilly Benefits From 'Broadening' GLP-1 Market, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2586392496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586392496?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:09","pubTimestamp":1764000569,"startTime":"0","endTime":"0","summary":"Eli Lilly  is benefiting from the \"broadening\" GLP-1 market for obesity and type-2 diabetes, Morgan Stanley said.The brokerage said in a Sunday note that the glucagon-like peptide-1, or GLP-1, market will continue to grow for both obesity and type-2 diabetes.Results from Morgan Stanley's survey suggest that Lilly could continue to gain market share versus Novo Nordisk  in these areas, with its Orfor drug potentially representing about 30% of the company's total GLP-1 mix a year after launch.The investment firm now expects the company to post revenue of $134 billion in 2030, up from a prior estimate of $115 billion. They project a 2030 operating margin of 56% and raised their earnings estimate to about $70 per share, up from $59 previously.The next catalysts for the Eli Lilly stock include phase 3 data from its Retatrutide weight-loss drug and phase 3 data from Novo Nordisk's Evoke Alzheimer's study, both expected in Q4.Morgan Stanley raised the stock's price target to $1,290 from $1,17","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0354030438.USD","LU0106831901.USD","LU2168564222.USD","LU1868837136.USD","BK4504","LU2168564495.EUR","LU0114720955.EUR","SG9999015945.SGD","LU2023251221.USD","LU1868836591.USD","LU2089283258.USD","BK4007","LU0912757837.SGD","LU1061106388.HKD","LU1548497426.USD","SG9999014906.USD","SGXZ99366536.SGD","LU1868836914.USD","GLP","LU1732800096.USD","LU2264538146.SGD","NVO.AU","LU2347655156.SGD","SG9999015952.SGD","LLY","LU1814569148.SGD","LU0823434740.USD","LU1720051108.HKD","IE0002141913.USD","LU1868837300.USD","SG9999001176.USD","MS","LU1868836757.USD","LU2750360997.AUD","LU2106854487.HKD","LU1069344957.HKD","SG9999014898.SGD","LU2087625088.SGD","LU1244550577.SGD","IE00BKVL7J92.USD","BK4127","LU0006306889.USD","IE00BWXC8680.SGD","LU0354030511.USD","LU0314104364.USD","SG9999018865.SGD","LU1323610961.USD","LU1057294990.SGD","LU0672654240.SGD"],"gpt_icon":1},{"id":"2585495608","title":"Safe Supply Secures Canadian Rights to GLP-1 Technology and Announces Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2585495608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585495608?lang=en_us&edition=fundamental","pubTime":"2025-11-24 23:38","pubTimestamp":1763998696,"startTime":"0","endTime":"0","summary":"Origin Therapeutics Holdings, Inc. ( ($TSE:SPLY) ) has shared an announcement. Safe Supply Streaming Co Ltd. has secured exclusive Canadian rights ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/safe-supply-secures-canadian-rights-to-glp-1-technology-and-announces-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/safe-supply-secures-canadian-rights-to-glp-1-technology-and-announces-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2585446085","title":"MENU - ORDER AI Launches Worldwide on the Apple App Store, Delivering Real-Time High-Protein and GLP-1 Friendly Dining Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446085","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585446085?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:56","pubTimestamp":1763992560,"startTime":"0","endTime":"0","summary":"MENU – ORDER AI, the first real-time dining companion built specifically for GLP-1 users and health-conscious consumers, has officially launchedgloballyon the Apple App Store. Following strong early traction—rapid downloads, paid users, and growing interest from restaurants and medical professionals—the company is now expanding worldwide to support diners in every region.BOSTON, Nov. 24, 2025 /PRNewswire/ -- MENU – ORDER AI instantly analyzes any menu from any restaurant, café, or delivery platform and highlights personalised meal options such as High-Protein, GLP-1 Friendly, Low-Carb, and Low WW Points. The app was created to solve one of the fastest-growing challenges in dining today: helping people make confident, healthy choices in real time, without guesswork or overwhelm.The global launch follows recent press coverage originating from a widely circulated announcement titled \"Revolutionary App MENU ORDER AI Now Available on the App Store – The First Real-Time Dining Companion for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/menu--order-ai-launches-worldwide-on-the-apple-app-store-delivering-real-time-high-protein-and-glp-1-friendly-dining-guidance-302624558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","LU0823434583.USD","SG9999017495.SGD","LU0979878070.USD","LU2430703251.USD","LU0061474960.USD","BK4533","LU0109392836.USD","IE00BKDWB100.SGD","IE00BFSS7M15.SGD","GB00BDT5M118.USD","LU2458330243.SGD","LU2237443549.SGD","SG9999000418.SGD","BK4534","LU1989772840.SGD","MACW.SI","LU1935043023.USD","SG9999015952.SGD","LU2357305700.SGD","LU2361044949.HKD","IE0003U64NQ7.SGD","GLP","LU2265009873.SGD","IE0001KFT4U8.USD","LU0061475181.USD","LU0784384876.USD","SG9999015986.USD","BK4573","AI","SG9999014898.SGD","SG9999014559.SGD","LU1868836591.USD","LU0528227936.USD","LU1037948541.HKD","BK4512","LU1989764664.SGD","LU0784385840.USD","LU2361044865.SGD","LU1720051017.SGD","LU2237443978.SGD","BK4532","BK4543","LU2543165471.USD","BK4581","LU0683600562.USD","LU2237443622.USD","LU0823434740.USD","LU1989772923.USD"],"gpt_icon":1},{"id":"2585144436","title":"Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joined the $1 trillion market cap club.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585144436","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585144436?lang=en_us&edition=fundamental","pubTime":"2025-11-21 23:40","pubTimestamp":1763739600,"startTime":"0","endTime":"0","summary":"Drugmaker Eli Lilly briefly joined the $1 trillion market cap club.The milestone is the result of the drugmaker's calculated strategy to dominate the market for obesity medications. Eli Lilly briefly crossed the $1 trillion market cap threshold, the first drug maker to ever reach that milestone.Eli Lilly is the first pharmaceutical stock to hit a $1 trillion valuation, even if it was only for a couple minutes, driven by its methodical approach to capturing an obesity drug market that didn't exist five years ago.The Indianapolis drug giant's stock  reached an intraday high of $1,061.17 in morning trading Friday, which was above the threshold of $1,057.78 needed for Lilly to become the 10th U.S. company with a $1 trillion market capitalization. It's the only health care company that has made the cut.Lilly is winning with its diverse pipeline of novel drugs, promising tirzepatide combinations and an exciting obesity pill in development in addition to its work on aging-related conditions l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ca170ab449593ee7dbc96b57871a781f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1629891620.HKD","LU1551013342.USD","SG9999001176.SGD","LLY","LU0072461881.USD","2NVD.UK","LU0889565916.HKD","NVD","BK4592","BK4567","LU0353189763.USD","LU1989764748.USD","LU1242518857.USD","NVD3.UK","LU2403377893.USD","LU2191332357.HKD","LU1992135399.USD","IE00BQXX3F31.USD","USAW.SI","LU2272731782.SGD","SNVD.UK","LU2471134796.USD","NVDD","IE00B7SZLL34.SGD","NVD2.UK","LU2250418816.HKD","NVIW.SI","LU0266013472.USD","LU0444971666.USD","NVDS","NVDY","LU1861127337.USD","LU2087625088.SGD","3NVD.UK","BK4559","IE000YTNTUN2.SGD","IE00BHPRN162.USD","GLP","BK4608","BK4579","LU1066051225.USD","BK4527","NVDS.UK","NVDU","LU1116320737.USD"],"gpt_icon":1},{"id":"2585214410","title":"Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's","url":"https://stock-news.laohu8.com/highlight/detail?id=2585214410","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585214410?lang=en_us&edition=fundamental","pubTime":"2025-11-21 23:36","pubTimestamp":1763739360,"startTime":"0","endTime":"0","summary":"Novo's upcoming Alzheimer's trial results will test whether Rybelsus can slow cognitive decline and reshape treatment expectations for GLP-1 drugs.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/21/Novo-Nordisk.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/21/Novo-Nordisk.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/11/49005033/novo-nordisk-will-soon-reveal-whether-its-glp-1-drug-can-slow-alzheimers","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/11/49005033/novo-nordisk-will-soon-reveal-whether-its-glp-1-drug-can-slow-alzheimers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU2750360997.AUD","LU0154236417.USD","GLP","LU2237443978.SGD","LU1291159041.SGD","LU1127390331.HKD","LU0820561909.HKD","LU2471134796.USD","SGXZ51526630.SGD","LU1868837136.USD","LU2063271972.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","SGXZ99366536.SGD","LU0256863902.USD","LU0109391861.USD","LU0823434740.USD","LU1093756168.USD","IE00B19Z9P08.USD","LU2108987350.USD","LU1868836591.USD","LU0466842654.USD","LU2265009873.SGD","LU1974910355.USD","LU1267930730.SGD","LU1989771016.USD","LU2237443549.SGD","BK4581","GB00BDT5M118.USD","LU1868836757.USD","LU2237443622.USD","LU1023059063.AUD","LU1366192091.USD","LU0432979614.USD","LU2750360641.GBP","SG9999001176.USD","BIIB","LU0006306889.USD","LU0061475181.USD","IE00BJLML261.HKD","LU2087625088.SGD","LU1069344957.HKD","LU2357305700.SGD","IE0004445239.USD","NVO","SG9999015978.USD","LU2461242641.AUD","LU0320765992.SGD","LU0079474960.USD"],"gpt_icon":1},{"id":"2585014555","title":"Market Chatter: Eli Lilly, Novo Nordisk to Offer GLP-1 Drugs Direct to Employers","url":"https://stock-news.laohu8.com/highlight/detail?id=2585014555","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585014555?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:27","pubTimestamp":1763731635,"startTime":"0","endTime":"0","summary":"Eli Lilly  and Novo Nordisk  are set to begin offering their popular GLP-1 medications to employers at fixed prices, avoiding rebates and fees that typically arise with traditional drug sales channels,  Bloomberg reported Friday.Lilly's Zepbound and Novo Nordisk's Wegovy will be sold to companies through digital health firm Waltz Health starting Jan. 1, the report said.A number of companies have expressed interest in the offer, with four employer clients ready to launch the offering in January, Reuters reported, citing Waltz chief executive officer Mark Thierer.The offering is targeted to employers that currently don't offer weight management drugs, the report said.\"Transparent initiatives like these enable more employers to opt in to coverage for authentic, FDA-approved GLP-1medicines while providing people who need care with a seamless experience that allows them to prioritize their health,\" a Novo Nordisk spokesperson said in an email to MT Newswires.Lilly did not immediately reply ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU1551013425.SGD","LU1868836757.USD","LU0266013472.USD","SG9999013999.USD","SG9999014906.USD","LU2471134796.USD","GLP","LU0432979614.USD","LU2471134952.CNY","NVO","LU0323591593.USD","LU2361044865.SGD","LU0786609619.USD","LU1720051017.SGD","LU1057294990.SGD","LU1551013342.USD","LU2471134523.USD","LU0823434583.USD","IE00B1XK9C88.USD","LU0097036916.USD","LU0256863902.USD","LU0640476718.USD","LU0354030438.USD","IE00BKDWB100.SGD","LU0823434740.USD","IE00BK4W5M84.HKD","LU0238689110.USD","EIG","LLY","IE00B1BXHZ80.USD","LU0353189763.USD","BK4588","LU2236285917.USD","LU1069344957.HKD","LU0823416689.USD","IE00BK4W5L77.USD","LU0882574139.USD","LU2471134879.HKD","LU0354030511.USD","SG9999015945.SGD","LU0256863811.USD","IE00B2B36J28.USD","LU1093756325.SGD","NVO.AU","LU1804176565.USD","LU2361044949.HKD","LU2089984988.USD","BK7104","LU1917777945.USD"],"gpt_icon":1},{"id":"2584183421","title":"What's Driving InMed's (INM) 22% After-Hours Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584183421","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584183421?lang=en_us&edition=fundamental","pubTime":"2025-11-20 15:28","pubTimestamp":1763623737,"startTime":"0","endTime":"0","summary":"InMed shares jumped 22% in after-hours trading after the company reported encouraging large-animal study results for its Alzheimer&#39;s drug candidate INM-901.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48968515/whats-driving-inmeds-inm-22-after-hours-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4144","GLP","BK4590","INM"],"gpt_icon":0},{"id":"1181584191","title":"Novo Nordisk Cuts Cash Price for GLP-1 Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1181584191","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181584191?lang=en_us&edition=fundamental","pubTime":"2025-11-19 00:20","pubTimestamp":1763482818,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) shares fell 2.1% in early U.S. trading on Tuesday following reports that the company reduced the direct price of Wegovy and Ozempic to $349 per month (with an introductory dose...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","BK4590","BK4588","BK4599","BK4532","LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","LU1093756168.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4144","BK4585","GLP"],"gpt_icon":0},{"id":"2584927933","title":"Oprah Winfrey-Backed Wellness Stock Stumbles As GLP-1 Boom Reshapes Consumer Habits: Growth Score Plummets","url":"https://stock-news.laohu8.com/highlight/detail?id=2584927933","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584927933?lang=en_us&edition=fundamental","pubTime":"2025-11-18 17:26","pubTimestamp":1763457960,"startTime":"0","endTime":"0","summary":"Prominent weight-loss and wellness company, WW International Inc. (NASDAQ: WW), backed by renowned talk show host Oprah Winfrey, has seen better days, with the company filing for bankruptcy early this year, and continuing to teeter on the edge after relisting on the Nasdaq.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/18/Indianapolis---Circa-August-2020-Ww-Inte.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/18/Indianapolis---Circa-August-2020-Ww-Inte.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/11/48917621/oprah-winfrey-backed-wellness-stock-stumbles-as-glp-1-boom-reshapes-consumer-habits-growth-score-plummets","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48917621/oprah-winfrey-backed-wellness-stock-stumbles-as-glp-1-boom-reshapes-consumer-habits-growth-score-plummets","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU2237443465.HKD","LU2461242641.AUD","BK4588","LU0708995401.HKD","LU0094547139.USD","LU0889565916.HKD","IE00B1XK9C88.USD","LU0353189763.USD","LU2324357040.USD","LU0786609619.USD","BK4144","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU2237438978.USD","IE00B1BXHZ80.USD","LU2602419157.SGD","LU0432979614.USD","LU1064131342.USD","LU0820561818.USD","LU0640476718.USD","LU0385154629.USD","LU1232071149.USD","IE00BJLML261.HKD","LU0256863811.USD","LU2552382215.SGD","LU2360106947.USD","LU0256863902.USD","LU2236285917.USD","LU0320765059.SGD","LU2265009873.SGD","BK4192","BK4585","LU0316494557.USD","LU1280957306.USD","LU0466842654.USD","LU0456855351.SGD","LU0689472784.USD","GB00BDT5M118.USD","SGXZ81514606.USD","LU0471298694.HKD","IE00BKDWB100.SGD","WW","LU2112291526.USD","LU0097036916.USD","LU2456880835.USD","GLP","LU1988902786.USD","LU0061475181.USD"],"gpt_icon":1},{"id":"1191784609","title":"Sinolink Securities: GLP-1 Product Iteration Drives Market Expansion, Focus on Target, Formulation, and Combination Therapy R&D Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1191784609","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191784609?lang=en_us&edition=fundamental","pubTime":"2025-11-18 14:10","pubTimestamp":1763446224,"startTime":"0","endTime":"0","summary":"The GLP-1 market remains one of the most closely watched sectors in the pharmaceutical industry, with the top two drugs projected to generate nearly $50 billion in sales in 2024. The market continues...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK4590","BK0028","GLP","BK0276","BK0012","BK0183","600109","BK4144","BK0201"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}